abstract |
FIELD: medicine. n SUBSTANCE: present group of inventions relates to medicine, namely to haematology and can be used for normalising impaired haemostasis. Methods include administering a clotting factor treatment consisting of FII, PCC and a three factor combination of FII, FX and FVIIa or fibrinogen and FII. n EFFECT: use of these inventions enables to reduce the risk of thromboembolic complications. n 24 cl, 12 dwg, 2 ex |